SCHEMBL23958972

SCHEMBL23958972

Cc1cnc2ccc(C(=O)NF)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.46
CYP1A2 P05177 2/20 0.45
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
KDM4E B2RXH2 3/20 0.44
MITF O75030 1/20 0.44
XBP1 P17861 1/20 0.44
PAX8 Q06710 1/20 0.44
KLF5 Q13887 1/20 0.44
TDP1 Q9NUW8 1/20 0.40
KLKB1 P03952 2/20 0.40
MAP4K1 Q92918 2/20 0.40
POLB P06746 1/20 0.40
LCK P06239 1/20 0.40
KDR P35968 1/20 0.40
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
ALPL P05186 1/20 0.38
GCG P01275 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27619377 0.82 CYP1A2 (0.52) PLK1CYP1A2NPC1RAB9AKDM4E
SCHEMBL24117372 0.81 CYP2A6 (0.56) PLK1CYP1A2NPC1RAB9AKDM4E
SCHEMBL13597529 0.80 HTT (0.61) CYP1A2NPC1RAB9AKDM4EMITF
SCHEMBL31435495 0.80 HTT (0.61) CYP1A2NPC1RAB9AKDM4EMITF
SCHEMBL16205920 0.80 PARP1 (0.49) CYP1A2LCKALPLSMN1; SMN2KMT2A
SCHEMBL30024398 0.76 PLK1 (0.47) PLK1CYP1A2NPC1RAB9AKDM4E
SCHEMBL10102364 0.76 ALDH1A1 (0.54) CYP1A2NPC1RAB9AKDM4EMITF
SCHEMBL4430795 0.75 NPC1 (0.57) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL30024818 0.74 KLKB1 (0.49) KLKB1MAP4K1
SCHEMBL28666318 0.73 MGAM (0.65) CYP1A2NPC1RAB9AKDM4EMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed